Skip to main content

Table 2 Formulations’ matrices

From: Development and characterization of mupirocin encapsulated in animal bone-derived hydroxyapatite for management of chronic wounds

Formulations

MUP (%w/v)

HAP (%w/v)

Transcutol (%v/v)

Carbopol (%w/v)

Propyl paraben (%w/v)

Methyl paraben (%w/v)

Propelene glycol (%v/v)

HAP

     ------

10

0.6

0.5

0.01

0.02

20

MUP/O

Conventional mupirocin ointment

BMM

2

10

0.6

0.5

0.01

0.02

20

CMM

2

10

0.6

0.5

0.01

0.02

20